• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Study shows Nilvadipine slows early-stage Alzheimer’s disease

    CLINICAL TRIAL

    Study shows Nilvadipine slows early-stage Alzheimer’s disease

    REUTERS

    New Roskamp Institute Clinical Research Shows Promise of Drug to Slow

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.